Two Sigma Investments, LP Arcturus Therapeutics Holdings Inc. Transaction History

Two Sigma Investments, LP

  • $59 Billion
  • Q3 2025

A detailed history of Two Sigma Investments, LP transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 89,219 shares of ARCT stock, worth $648,622. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,219
Previous 86,362 3.31%
Holding current value
$648,622
Previous $1.12 Million 46.39%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$11.39 - $22.17 $32,541 - $63,339
2,857 Added 3.31%
89,219 $1.64 Million
Q2 2025

Aug 14, 2025
BUY
$8.91 - $14.41 $436,652 - $706,190
49,007 Added 131.19%
86,362 $1.12 Million
Q1 2025

May 15, 2025
BUY
$10.59 - $20.83 $103,729 - $204,029
9,795 Added 35.54%
37,355 $395,000
Q4 2024

Feb 14, 2025
BUY
$14.82 - $25.48 $154,572 - $265,756
10,430 Added 60.89%
27,560 $467,000
Q3 2024

Nov 14, 2024
BUY
$18.08 - $25.38 $68,920 - $96,748
3,812 Added 28.62%
17,130 $397,000
Q2 2024

Aug 14, 2024
SELL
$24.35 - $44.39 $22,937 - $41,815
-942 Reduced 6.61%
13,318 $324,000
Q1 2024

May 15, 2024
SELL
$31.23 - $42.99 $356,022 - $490,086
-11,400 Reduced 44.43%
14,260 $481,000
Q4 2023

Feb 14, 2024
BUY
$17.71 - $32.97 $90,321 - $168,147
5,100 Added 24.81%
25,660 $809,000
Q3 2023

Nov 14, 2023
BUY
$25.44 - $37.35 $12,720 - $18,675
500 Added 2.49%
20,560 $525,000
Q2 2023

Aug 14, 2023
BUY
$23.94 - $32.36 $205,884 - $278,296
8,600 Added 75.04%
20,060 $575,000
Q1 2023

May 15, 2023
BUY
$14.72 - $23.97 $168,691 - $274,696
11,460 New
11,460 $274,000
Q4 2021

Feb 14, 2022
SELL
$34.2 - $47.56 $254,584 - $354,036
-7,444 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$27.88 - $58.25 $8.87 Million - $18.5 Million
-318,049 Reduced 97.71%
7,444 $356,000
Q2 2021

Aug 16, 2021
SELL
$25.79 - $42.11 $1.73 Million - $2.83 Million
-67,210 Reduced 17.11%
325,493 $11 Million
Q1 2021

May 17, 2021
BUY
$38.75 - $86.92 $8.9 Million - $20 Million
229,613 Added 140.79%
392,703 $16.2 Million
Q4 2020

Feb 16, 2021
SELL
$34.61 - $123.66 $3.92 Million - $14 Million
-113,228 Reduced 40.98%
163,090 $7.08 Million
Q3 2020

Nov 16, 2020
BUY
$37.49 - $63.19 $6.88 Million - $11.6 Million
183,572 Added 197.93%
276,318 $11.9 Million
Q2 2020

Aug 14, 2020
BUY
$12.66 - $58.27 $882,452 - $4.06 Million
69,704 Added 302.51%
92,746 $4.34 Million
Q1 2020

May 15, 2020
SELL
$9.31 - $18.26 $489,892 - $960,841
-52,620 Reduced 69.55%
23,042 $313,000
Q4 2019

Feb 14, 2020
BUY
$8.93 - $12.41 $543,551 - $755,371
60,868 Added 411.44%
75,662 $822,000
Q3 2019

Nov 14, 2019
BUY
$8.8 - $14.5 $130,187 - $214,513
14,794 New
14,794 $152,000

Others Institutions Holding ARCT

# of Institutions
171
Shares Held
26.2M
Call Options Held
2.32M
Put Options Held
866K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $193M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email